GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (STU:WPS) » Definitions » 1-Year ROIIC %

West Pharmaceutical Services (STU:WPS) 1-Year ROIIC % : -28.65% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is West Pharmaceutical Services 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. West Pharmaceutical Services's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was -28.65%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for West Pharmaceutical Services's 1-Year ROIIC % or its related term are showing as below:

STU:WPS's 1-Year ROIIC % is ranked worse than
68.03% of 832 companies
in the Medical Devices & Instruments industry
Industry Median: 1.98 vs STU:WPS: -28.65

West Pharmaceutical Services 1-Year ROIIC % Historical Data

The historical data trend for West Pharmaceutical Services's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services 1-Year ROIIC % Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.11 65.50 97.44 -8.54 -22.00

West Pharmaceutical Services Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.30 -22.00 -31.08 -39.92 -28.65

Competitive Comparison of West Pharmaceutical Services's 1-Year ROIIC %

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's 1-Year ROIIC % falls into.



West Pharmaceutical Services 1-Year ROIIC % Calculation

West Pharmaceutical Services's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 441.9221 (Sep. 2024) - 535.2749 (Sep. 2023) )/( 2565.057 (Sep. 2024) - 2371.36 (Sep. 2023) )
=-93.3528/193.697
=-48.20%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


West Pharmaceutical Services  (STU:WPS) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


West Pharmaceutical Services 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania, us, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services Headlines